【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 18
2 Introduction 19
2.1 Neurological Diagnostic Equipment Overview 19
3 Products under Development 20
3.1 Neurological Diagnostic Equipment – Pipeline Products by Stage of Development 20
3.2 Neurological Diagnostic Equipment – Pipeline Products by Segment 21
3.3 Neurological Diagnostic Equipment – Pipeline Products by Territory 22
3.4 Neurological Diagnostic Equipment – Pipeline Products by Regulatory Path 23
3.5 Neurological Diagnostic Equipment – Pipeline Products by Estimated Approval Date 24
3.6 Neurological Diagnostic Equipment – Ongoing Clinical Trials 25
4 Neurological Diagnostic Equipment – Pipeline Products under Development by Companies 26
4.1 Neurological Diagnostic Equipment Companies – Pipeline Products by Stage of Development 26
4.2 Neurological Diagnostic Equipment – Pipeline Products by Stage of Development 31
5 Neurological Diagnostic Equipment Companies and Product Overview 36
5.1 Acreo Swedish ICT AB Company Overview 36
5.1.1 Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.2 ADM Diagnostics, LLC Company Overview 37
5.2.1 ADM Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Ad-Tech Medical Instrument Corporation Company Overview 38
5.3.1 Ad-Tech Medical Instrument Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.4 Advanced Brain Monitoring, Inc. Company Overview 39
5.4.1 Advanced Brain Monitoring, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.5 Advanced Diamond Technologies, Inc. Company Overview 41
5.5.1 Advanced Diamond Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 advanced neurometrics inc. Company Overview 42
5.6.1 advanced neurometrics inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Barron Associates, Inc. Company Overview 43
5.7.1 Barron Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 BioLert Electro Medical Systems Company Overview 45
5.8.1 BioLert Electro Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 45
5.9 Bio-Signal Group Corp. Company Overview 46
5.9.1 Bio-Signal Group Corp. Pipeline Products & Ongoing Clinical Trials Overview 46
5.10 BioSignostix Inc. Company Overview 48
5.10.1 BioSignostix Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 BiReme Pty Ltd Company Overview 49
5.11.1 BiReme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Brain Sentinel Company Overview 50
5.12.1 Brain Sentinel Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 BrainCare OY Company Overview 53
5.13.1 BrainCare OY Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Brainchem, LLC Company Overview 54
5.14.1 Brainchem, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 BrainScope Company, Inc. Company Overview 56
5.15.1 BrainScope Company, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.16 Braintech Ltd. Company Overview 65
5.16.1 Braintech Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.17 Cerora, Inc. Company Overview 66
5.17.1 Cerora, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.18 Children’s Hospital & Research Center Oakland Company Overview 67
5.18.1 Children’s Hospital & Research Center Oakland Pipeline Products & Ongoing Clinical Trials Overview 67
5.19 Cleveland Medical Devices, Inc. Company Overview 69
5.19.1 Cleveland Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
5.20 Cognionics, Inc. Company Overview 71
5.20.1 Cognionics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.21 Cognitive Sensing Inc. Company Overview 72
5.21.1 Cognitive Sensing Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.22 Columbia University Medical Center Company Overview 73
5.22.1 Columbia University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 73
5.23 Converge Medical, Inc Company Overview 74
5.23.1 Converge Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.24 Convergence Medical Devices Company Overview 75
5.24.1 Convergence Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 75
5.25 Cortec GmbH Company Overview 76
5.25.1 Cortec GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
5.26 Cyberonics, Inc. Company Overview 78
5.26.1 Cyberonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.27 Dartmouth College Company Overview 80
5.27.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 80
5.28 DMetrix, Inc. Company Overview 81
5.28.1 DMetrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.29 Drexel University Company Overview 83
5.29.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 83
5.30 EIC Laboratories, Inc. Company Overview 84
5.30.1 EIC Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
5.31 Electrical Geodesics, Inc. Company Overview 85
5.31.1 Electrical Geodesics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.32 ElMinda Ltd. Company Overview 92
5.32.1 ElMinda Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.33 Epitel, Inc. Company Overview 101
5.33.1 Epitel, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Exploit Technologies Pte Ltd Company Overview 102
5.34.1 Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 Flint Hills Scientific, LLC Company Overview 104
5.35.1 Flint Hills Scientific, LLC Pipeline Products & Ongoing Clinical Trials Overview 104
5.36 Greatbatch, Inc. Company Overview 106
5.36.1 Greatbatch, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.37 HeadSense Medical Ltd. Company Overview 109
5.37.1 HeadSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 109
5.38 HEARD Medical Company Overview 112
5.38.1 HEARD Medical Pipeline Products & Ongoing Clinical Trials Overview 112
5.39 Henry Ford Health System Company Overview 113
5.39.1 Henry Ford Health System Pipeline Products & Ongoing Clinical Trials Overview 113
5.40 i360medical Limited Company Overview 115
5.40.1 i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 115
5.41 IMEC Company Overview 116
5.41.1 IMEC Pipeline Products & Ongoing Clinical Trials Overview 116
5.42 Imperial College London Company Overview 117
5.42.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 117
5.43 Incereb Medical Ltd. Company Overview 119
5.43.1 Incereb Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 119
5.44 Infinite Biomedical Technologies, LLC Company Overview 121
5.44.1 Infinite Biomedical Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 121
5.45 InfraScan, Inc. Company Overview 123
5.45.1 InfraScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.46 Integra LifeSciences Holdings Corporation Company Overview 125
5.46.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.47 Integrated Sensing Systems, Inc. Company Overview 127
5.47.1 Integrated Sensing Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Jan Medical, Inc. Company Overview 129
5.48.1 Jan Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.49 KeepAlive Medical Ltd Company Overview 133
5.49.1 KeepAlive Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 133
5.50 Koronis Biomedical Technologies Corporation Company Overview 134
5.50.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 134
5.51 Lara Diagnostics AB Company Overview 135
5.51.1 Lara Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 135
5.52 Leap Medical Inc. Company Overview 136
5.52.1 Leap Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.53 Massachusetts Institute of Technology Company Overview 137
5.53.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 137
5.54 McGill University Company Overview 139
5.54.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 139
5.55 Medfield Diagnostics AB Company Overview 141
5.55.1 Medfield Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 141
5.56 Medisens Wireless, Inc. Company Overview 145
5.56.1 Medisens Wireless, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.57 Mindful Scientific Inc. Company Overview 147
5.57.1 Mindful Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.58 Neba Health, LLC Company Overview 148
5.58.1 Neba Health, LLC Pipeline Products & Ongoing Clinical Trials Overview 148
5.59 Neural Analytics, Inc. Company Overview 150
5.59.1 Neural Analytics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.60 Neural Diagnostics Pty Ltd Company Overview 151
5.60.1 Neural Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 151
5.61 Neuro Assessment Systems Company Overview 155
5.61.1 Neuro Assessment Systems Pipeline Products & Ongoing Clinical Trials Overview 155
5.62 Neuro Devices, Inc. Company Overview 157
5.62.1 Neuro Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.63 Neuro Kinetics, Inc. Company Overview 159
5.63.1 Neuro Kinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159
5.64 NeuroDx Development LLC Company Overview 161
5.64.1 NeuroDx Development LLC Pipeline Products & Ongoing Clinical Trials Overview 161
5.65 NeuroInDx, Inc. Company Overview 162
5.65.1 NeuroInDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.66 Neurokeeper Technologies Company Overview 163
5.66.1 Neurokeeper Technologies Pipeline Products & Ongoing Clinical Trials Overview 163
5.67 NeuroMetrix, Inc. Company Overview 166
5.67.1 NeuroMetrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.68 NeuroVigil, Inc. Company Overview 169
5.68.1 NeuroVigil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169
5.69 NeuroWave Systems Inc. Company Overview 171
5.69.1 NeuroWave Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.70 NexGen Medical Systems, Inc. Company Overview 174
5.70.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 174
5.71 North Carolina State University Company Overview 175
5.71.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 175
5.72 Northwestern University Company Overview 177
5.72.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 177
5.73 NovoView Diagnostics LLC Company Overview 178
5.73.1 NovoView Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 178
5.74 Oculogica Inc. Company Overview 179
5.74.1 Oculogica Inc. Pipeline Products & Ongoing Clinical Trials Overview 179
5.75 Optima Neuroscience, Inc. Company Overview 180
5.75.1 Optima Neuroscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 180
5.76 Orsan Medical Technologies Ltd. Company Overview 181
5.76.1 Orsan Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 181
5.77 QUASAR, Inc. Company Overview 182
5.77.1 QUASAR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
5.78 ReHaptix GmbH Company Overview 183
5.78.1 ReHaptix GmbH Pipeline Products & Ongoing Clinical Trials Overview 183
5.79 SensoDetect AB Company Overview 184
5.79.1 SensoDetect AB Pipeline Products & Ongoing Clinical Trials Overview 184
5.80 SFC Fluidics LLC Company Overview 188
5.80.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 188
5.81 Smart Monitor Company Overview 189
5.81.1 Smart Monitor Pipeline Products & Ongoing Clinical Trials Overview 189
5.82 SoNovum AG Company Overview 190
5.82.1 SoNovum AG Pipeline Products & Ongoing Clinical Trials Overview 190
5.83 Southeast TechInventures, Inc. Company Overview 191
5.83.1 Southeast TechInventures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 191
5.84 Spectros Corporation Company Overview 192
5.84.1 Spectros Corporation Pipeline Products & Ongoing Clinical Trials Overview 192
5.85 Spire Corporation Company Overview 193
5.85.1 Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 Stanford University Company Overview 194
5.86.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 Swansea University Company Overview 195
5.87.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 195
5.88 Swiss Federal Institute of Technology Zurich Company Overview 196
5.88.1 Swiss Federal Institute of Technology Zurich Pipeline Products & Ongoing Clinical Trials Overview 196
5.89 Tel Aviv University Company Overview 198
5.89.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 198
5.90 The Feinstein Institute for Medical Research Company Overview 199
5.90.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 199
5.91 The Tel Aviv Sourasky Medical Center Company Overview 201
5.91.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 201
5.92 The University of Queensland Company Overview 202
5.92.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 202
5.93 Third Eye Diagnostics, Inc. Company Overview 203
5.93.1 Third Eye Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.94 Tristan Technologies, Inc. Company Overview 204
5.94.1 Tristan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
5.95 University College Cork Company Overview 206
5.95.1 University College Cork Pipeline Products & Ongoing Clinical Trials Overview 206
5.96 University of California, Berkeley Company Overview 207
5.96.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 207
5.97 University of California, Los Angeles Company Overview 209
5.97.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 209
5.98 University of California, San Diego Company Overview 210
5.98.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 210
5.99 University of Cambridge Company Overview 214
5.99.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 214
5.100 University of Cantabria Company Overview 216
5.100.1 University of Cantabria Pipeline Products & Ongoing Clinical Trials Overview 216
5.101 University of Canterbury Company Overview 217
5.101.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview 217
5.102 University of Cincinnati Company Overview 218
5.102.1 University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 218
5.103 University of Colorado Company Overview 220
5.103.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 220
5.104 University of Florida Company Overview 222
5.104.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 222
5.105 University of Hertfordshire Company Overview 225
5.105.1 University of Hertfordshire Pipeline Products & Ongoing Clinical Trials Overview 225
5.106 University of Illinois Company Overview 226
5.106.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 226
5.107 University of Michigan Company Overview 227
5.107.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 227
5.108 University of Pennsylvania Company Overview 230
5.108.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 230
5.109 VisionQuest Biomedical, LLC Company Overview 232
5.109.1 VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 232
5.110 Vittamed Corporation Company Overview 234
5.110.1 Vittamed Corporation Pipeline Products & Ongoing Clinical Trials Overview 234
5.111 Vivonics, Inc. Company Overview 236
5.111.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 236
5.112 Washington and Lee University Company Overview 237
5.112.1 Washington and Lee University Pipeline Products & Ongoing Clinical Trials Overview 237
5.113 Wisconsin Institute of Nuclear Systems Company Overview 238
5.113.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 238
6 Neurological Diagnostic Equipment- Recent Developments 240
7 Appendix 263
7.1 Methodology 263
7.2 About GlobalData 265
7.3 Contact Us 266
7.4 Disclaimer 266
【レポート販売概要】
■ タイトル：世界の神経診断装置開発動向：医療機器パイプライン分析2015■ 英文：Neurological Diagnostic Equipment - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0146EPD
■ 調査対象地域：グローバル
- 義歯の世界市場2019-2023About this market Edentulism or tooth loss is a condition characterized by the partial or complete loss of teeth as a result of injury or diseases such as tooth decay, tooth trauma, or gum disease. Edentulism is common among older people and affects the person's facial appearance and ability to eat and talk. Also, the growing incidence of causative factors on dental health such as smoking, alcohol …
- トートバッグの世界市場2019-2023About this market The increasing marketing campaigns and product as well as brand promotion activities will trigger the market’s growth in the forthcoming years. Vendors are investing significantly to focus on consumer engagement, increasing brand awareness, reinforcement of brand relevance, and consumer guidance to stores or shopping websites. The market players are also using various methods for …
- 化学療法に伴う肢端紅斑（手足症候群）：世界の臨床試験レビュー（2014年上半期）Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) clinical trial scenario. This report provides elemental information and data relat …
- 薫製魚の世界市場2018-2022133 Pages, November 2018 About this market The rising popularity of online shopping is identified as one of the key trends that will gain traction in the market. It is encouraging various manufacturers to explore the online retail format and concentrate on the internet-savvy consumer segment. Operating costs and overheads for vendors are lower in the online retail format in comparison to the physi …
- 世界のソフトウェア・コンフィギュレーション管理市場動向（2012-2016）TechNavio's analysts forecast the Global Software Configuration Management market to grow at a CAGR of 7.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand of risk management. The Global Software Configuration Management market has also been witnessing the increasing popularity of software configuration management solutions amon …
- 過眠症（Hypersomnia）：グローバル臨床試験動向（2014年上半期）Hypersomnia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hypersomnia Global Clinical Trials Review, H1, 2014" provides data on the Hypersomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersomnia. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 世界の熱媒体流体市場動向及び予測（～2019）Heat transfer fluids have found a wide acceptance in various industries, because of their distinguished properties. Based on application areas, the market of heat transfer fluids can broadly be segmented into oil & gas, concentrating solar power, chemical industry, manufacturing processes, pharmaceuticals, bio-diesel production, and others. Though oil & gas and concentrating solar power markets ar …
- 世界の性行為感染症（STD）検査市場About this ReportThis report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market se …
- RFIDミドルウェア（RFIDマネージャー）の世界市場2019-2023Global RFID Middleware Market: About this market Technavio’s RFID middleware market analysis considers sales from industrial, transportation, retail, healthcare, and others. Our analysis also considers the sales of RFID middleware in APAC, Europe, North America, South America, and MEA. In 2018, the industrial segment had a significant market share, and this trend is expected to continue over the f …
- 先進高分子複合材料の世界市場：炭素繊維強化/ガラス繊維強化/アラミド繊維強化高分子複合材料About polymer composites Composites are made up of two or more materials with different properties, which are combined to exhibit unique characteristics. Polymer composites are made up of two major components: a polymer matrix and a reinforcing fiber material. A variety of fibers (like carbon, glass, and aramid) and polymer resins (such as epoxy, polyester, phenol, and polyacrylic) are used in man …
- コンパニオン診断（CDx）の世界市場予測2016-2026What can be expected from the Companion Diagnostics market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there. Our 192-page report provides 127 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you a …
- 歯科診断・手術装置の世界市場2019-2023About this market The worldwide prevalence of dental diseases and the associated risk factors are increasing significantly. The prevalence of oral cancer is also increasing in many countries. The prevalence of these dental diseases significantly increases with age. Globally, the number of old people is also growing rapidly owing to the rise in average life expectancy. In addition, the prevalence o …
- MLaaS（クラウド式機械学習サービス）の世界市場予測The Machine Learning as a Service Market size is estimated to grow from USD 613.4 Million in 2016 to USD 3,755.0 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 43.7% from 2016 to 2021. The main driving factors for the growth of the market are adoption of cloud-based technologies and advancements in technologies. Among Machine Learning as a Service Market services, the professional ser …
- Mitsubishi Corporation：石油・ガスバリューチェーン分析レポート2013Mitsubishi Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Mitsubishi Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Mitsubishi Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- シアン酸エステル樹脂の世界市場予測（～2022年）The global cyanate ester resin market is projected to reach USD 338.8 Million by 2022, at a CAGR of 11.7% from 2017 to 2022. Cyanate ester resins are organic compounds that are generally manufactured from cyanic acid and bisphenol A. Better dielectric properties of cyanate esters along with high strength and ease of processing make cyanate ester resins a choice of material for the composites appli …
